Recombinant pig cutaneous development protein (rrhEGF) is gaining increased recognition as a valuable technique in the area of tissue therapy. This bioactive agent, manufactured through recombinant engineering, offers a potent stimulus for tissue growth and migration, resulting to accelerated wou